Related Experiment Video

Updated: Jun 24, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1

Maria Giovanna di Bari1, M E Christine Lutsiak, Shinji Takai

  • 1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, MSC 1750, Bethesda, MD 20892, USA.

Cancer Immunology, Immunotherapy : CII
|March 26, 2009
PubMed

Insights

Tumor-infiltrating CD8+ T cells show reduced function due to TGF-beta. Inhibiting TGF-beta restores T cell activity and upregulates Spred-1, a potential target for anti-tumor immunity.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • CD8+ T cells are crucial for anti-tumor immunity but often become dysfunctional within the tumor microenvironment.
  • Transforming growth factor-beta (TGF-beta) is a key immunosuppressive cytokine implicated in tumor progression.
  • Understanding the mechanisms of T cell dysfunction is vital for developing effective cancer immunotherapies.

Purpose of the Study:

  • To investigate the role of TGF-beta in the hyporesponsiveness of tumor-infiltrating CD8+ T cells (TILs).
  • To identify molecular pathways and genes associated with TGF-beta-mediated T cell dysfunction in TILs.
  • To explore the potential of targeting TGF-beta signaling and associated molecules for enhancing anti-tumor immunity.

Main Methods:

  • Comparative analysis of CD8+ TILs and splenic CD8+ T cells.
  • Assessment of T-cell receptor (TCR) signaling pathways, including ITK and ERK kinase activation.
  • Treatment with a small molecule TGF-beta inhibitor.
  • Gene expression analysis, focusing on Spred-1 and its regulation by TGF-beta.

Main Results:

  • CD8+ TILs exhibited reduced functionality and hyporesponsiveness compared to splenic CD8+ T cells.
  • TGF-beta was identified as a major contributor to CD8+ TIL dysfunction, which was reversible with a TGF-beta inhibitor.
  • TGF-beta inhibition restored TCR signaling, including ITK and ERK kinase activation, in CD8+ TILs.
  • Spred-1, an inhibitor of the Ras/MAPK pathway, was found to be upregulated in CD8+ TILs.
  • TGF-beta enhanced Spred-1 expression in effector/memory CD8+ T cells, but not rested/memory cells.

Conclusions:

  • TGF-beta mediates an inhibitory mechanism on CD8+ TILs by blocking TCR signaling and upregulating Spred-1.
  • Spred-1 plays a significant role in TGF-beta-induced T cell dysfunction within the tumor microenvironment.
  • Spred-1 represents a potential novel therapeutic target for enhancing anti-tumor immune responses.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...